...
首页> 外文期刊>Scientific reports. >Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective
【24h】

Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective

机译:从结构/功能视角重新审视凝血因子XIII激活和调节的机制

获取原文

摘要

The activation and regulation of coagulation Factor XIII (FXIII) protein has been the subject of active research for the past three decades. Although discrete evidence exists on various aspects of FXIII activation and regulation a combinatorial structure/functional view in this regard is lacking. In this study, we present results of a structure/function study of the functional chain of events for FXIII. Our study shows how subtle chronological submolecular changes within calcium binding sites can bring about the detailed transformation of the zymogenic FXIII to its activated form especially in the context of FXIIIA and FXIIIB subunit interactions. We demonstrate what aspects of FXIII are important for the stabilization (first calcium binding site) of its zymogenic form and the possible modes of deactivation (thrombin mediated secondary cleavage) of the activated form. Our study for the first time provides a structural outlook of the FXIIIA2B2 heterotetramer assembly, its association and dissociation. The FXIIIB subunits regulatory role in the overall process has also been elaborated upon. In summary, this study provides detailed structural insight into the mechanisms of FXIII activation and regulation that can be used as a template for the development of future highly specific therapeutic inhibitors targeting FXIII in pathological conditions like thrombosis.
机译:凝血因子XIII(FXIII)蛋白的活化和调节是过去三十年积极研究的主题。尽管在FXIII激活和规例中存在离散证据,但在这方面的组合结构/功能视图缺乏。在这项研究中,我们呈现了对FXIII事件的功能链的结构/功能研究的结果。我们的研究表明,钙结合位点内的微妙时间沉鸡变化是如何引起酶原FXIII的详细转化,特别是在FXIIIA和FXIIIB亚基相互作用中的激活形式。我们证明了FXIII的各个方面对于其酶原形式的稳定(第一钙结合位点)和所激活的形式的可能的失活模式(凝血酶介导的二次切割)是重要的。我们首次进行的研究提供了FXIIIA2B2杂化物组件的结构前景,其结合和解离。 FXIIIB亚基在整体过程中的监管作用也被阐述。总之,本研究提供了对FXIII激活和调节的机制的详细结构洞察力,其可用作在血栓形成等血栓形成等病理条件下靶向FXIII的未来高度特异性治疗抑制剂的模板。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号